An increased risk of ovarian cancer has been associated with mutations in the MT‐CO1 gene [123], while the recent Pan‐Cancer Analysis of Whole Genomes (PCAWG) Consortium report MT‐CO1 as the most frequently mutated mtDNA protein‐encoding gene in breast, cervical and bladder cancers [80]. This evidence concerns the gene MT-CO1 and ovarian cancer.